Results 191 to 200 of about 4,013,382 (355)

Effects of Dietary Niacin Concentration and Protein Content on Gastric Acidity and Vitamin B₁₂ Binding Capacity of Gastric Mucosa in Rats

, 1968
Tatsuo Koyanagi, Shoji Yamada
openalex   +2 more sources

The nature of the enzymically catalysed binding of glucose to the protein coat of Colpoda steinii cysts [PDF]

, 1969
B.J. Marshall, J. Tibbs
openalex   +1 more source

A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner

Molecular Oncology, EarlyView.
We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp, Wouter P. R. Verdurmen, Jonas V. Schaefer, Kari Kopra, Gabriela Nagy‐Davidescu, Elodie Richard, Marie‐Julie Nokin, Patrick Ernst, Rastislav Tamaskovic, Martin Schwill, Ralph Degen, Claudia Scholl, David Santamaria, Andreas Plückthun   +13 more
wiley   +1 more source

The role of LRRC15-SCG5 in ECM protein binding as a prognostic signature for urothelial carcinoma. [PDF]

Am J Cancer Res
Dong SW, Chen CH, Tzou KY, Hu SW, Wu CC, Li CH.   +5 more
europepmc   +1 more source

The binding of sodium dodecyl sulphate to various proteins [PDF]

, 1968
Rosalind Pitt‐Rivers, F. S. Ambesi Impiombato   +1 more
openalex   +1 more source

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer

Molecular Oncology, EarlyView.
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald, Anna M. Reagan, Charles J. Bailey, Mei Gao, Muqiang Gao, Angelica L. Solomon, Michael J. Cavnar, Prakash K. Pandalai, Mautin T. Barry‐Hundeyin, Megan M. Harper, Justin A. Rueckert, Ángela Turrero, Araceli Tobio, Anxo Vidal, Daniel Roca‐Lema, Elia Álvarez‐Coiradas, Pablo Garrido, Laureano Simón, Joseph Kim   +18 more
wiley   +1 more source

Global analysis of excitotoxicity-induced alterations in RNA structure and RNA-protein binding in neurons. [PDF]

iScience
Alvarez-Periel E, Kramer MC, Akay-Espinoza C, Jackson DP, Tasca JA, Garcia BA, Gregory BD, Jordan-Sciutto KL.   +7 more
europepmc   +1 more source

Physicochemical Studies on the Binding of Chemicals with Proteins. VIII. : The Binding of Phenoxazone Compound with Serum Albumin

, 1967
Masayuki Nakagaki, Hiroshi Terada
openalex   +2 more sources

Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias, Ana Oitabén, Sonia Zumalave, Bernardo Rodriguez‐Martin, María Gallardo‐Gómez, Martín Santamarina, Ana Pequeño‐Valtierra, Laura Juaneda‐Magdalena, Ramón García‐Escudero, José Luis López‐Cedrún, Máximo Fraga, José M. C. Tubio, Mónica Martínez‐Fernández   +12 more
wiley   +1 more source

Identification of potential human targets for epigallocatechin gallate through a novel protein binding site screening approach. [PDF]

J Mol Model
Hirci J, Škufca S, Kunej T, Janežič D, Konc J.   +4 more
europepmc   +1 more source